Slide 1: Full Year 2024 Conference Call
Full Year 2024 Conference Call March 4, 2025
Slide 2: Forward Looking Statements
Forward Looking Statements Statements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans, or predictions of the future, are forward-looking statements within the meaning of the
Slide 3: Cryoport – Trusted Partner to Life Sciences Companies
Cryoport – Trusted Partner to Life Sciences Companies Life sciences company focused on providing mission critical, proprietary temperature-controlled supply chain solutions Capabilities include core competencies to ship, store and deliver biologics in a cryogenic or temperature- controlled state suc
Slide 4: Cryoport – Q4 2024 Snapshot
Cryoport – Q4 2024 Snapshot Performance Global Platform (2) 50+ Facilities in 17 Countries $59.5M $240 - $250M $262M Q4-2024 Revenue FY 2025 Revenue Cash & Short-Term Guidance investments C> Supply Chain Leader 3,000+ Global Clients $7.9M 701 1,100 Employees 19 13% of total revenue Active Cell & G
Slide 5: Cryoport Systems Supports a Growing Cell & Gene Therapy Clinical Trial Pipeline
Cryoport Systems Supports a Growing Cell & Gene Therapy Clinical Trial Pipeline ✓701 clinical trials (net) in aggregate Clinical Trials Supported by Trial ✓ 81 Phase III trials in the Americas, EMEA and APAC Phase as of 12/31/24 Increased by 26 trials (net) over Q4 2023 Source: Company materials cro
Slide 6: Cryoport Systems Commercial Revenue Growth
Cryoport Systems Commercial Revenue Growth © 2025 CRYOPORT, INC. 6
Slide 7: Cryoport Supports 19 Commercial Cell & Gene Therapies
Cryoport Supports 19 Commercial Cell & Gene Therapies AKUUGO® © 2025 CRYOPORT, INC. 7
Slide 8: Cell Therapy Market November 2024
Cell Therapy Market November 2024 Precision Allogene Sorrento Therapeutics Cellectis Phase I BioSciences Precision Therapeutics 2Seventy Bio BioSciences Innovent Biologics CD38 DAR-T Poseida Therapeutics Allogeneic CAR-T UCARTCS1 Atara PBCAR19B CD30 P-BCMA-ALLO1 bbT369 CD19 Azer-cel ALLO-316 CS1,SLA
Slide 9: Gene Therapy Landscape April 2024
Gene Therapy Landscape April 2024 © 2025 CRYOPORT, INC. 9
Slide 10: The Leading Cryogenic Systems Manufacturer in the World
The Leading Cryogenic Systems Manufacturer in the World MVE Biological Solutions is the leading manufacturer of cryogenic systems, providing cryogenic freezers, dewars, and related equipment used for cryogenic storage and transportation • Three primary locations o Ball Ground, GA o New Prague, MN o
Slide 11: CRYOGENE Will Be Exclusive Supplier to Speros/Moffitt Cancer Center
CRYOGENE Will Be Exclusive Supplier to Speros/Moffitt Cancer Center • 30,000 sq ft facility with exclusivity for biorepository services • Construction to begin Q2 2025 • Biological material transfers begin Q2 2026 • CRYOGENE will provide our services to biotech, research, and pharma companies in the
Slide 12: MVE Biological Solutions' FDA Registration
MVE Biological Solutions’ FDA Registration © 2025 CRYOPORT, INC. 12
Slide 13: CRYOPDP
CRYOPDP We provide customized solutions tailored to meet In one page our customers’ needs. With an extensive offer from Focused on Life Science and packaging, to transport and Healthcare added-value solutions 16 Countries Backed by a team of experienced professionals in the logistics and 39 Faciliti
Slide 14: Cryoport Systems' Proprietary Shipper Fleet
Cryoport Systems’ Proprietary Shipper Fleet Cryoport Express ® High Volume Dry Vapor Shipper CXHV3 CryoMax® Cryogenic -150° C or colder Lab Move Shipper C1536PD 21 days at -150°C or colder Cryoport Elite 28L Ultra Cryoport Elite 56L Ultra Cold Shipper ELUC128 Cold Shipper ELUC156 -60° C to -80° C -6
Slide 15: IntegriCell - a Unique Platform for Starting Materials
IntegriCell - a Unique Platform for Starting Materials A standardized cryopreservation and distribution solution for the global cell therapy market located in Villers le Bouillet, Belgium and Houston, Texas Apheresis Global Supply Chain Partners Centers Collection Cryopreservation Storage & Distribu
Slide 16: A Unified Network Supporting the Life Sciences
A Unified Network Supporting the Life Sciences 17 countries > 50 locations US IE Brentwood, Tennessee Dublin Irvine, California PL Morris Plains, New Jersey Warsaw Houston, Texas San Antonio, Texas PH Ball Ground, Georgia Manila New Prague, Minnesota KR Valley Stream, New York Seoul Huntington Beach
Slide 17: Upcoming Investor Conferences
Upcoming Investor Conferences © 2025 CRYOPORT, INC. 17